A detailed history of Fmr LLC transactions in Greenwich Life Sciences, Inc. stock. As of the latest transaction made, Fmr LLC holds 90 shares of GLSI stock, worth $1,340. This represents 0.0% of its overall portfolio holdings.

Number of Shares
90
Previous 90 -0.0%
Holding current value
$1,340
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$7.77 - $12.3 $23 - $36
-3 Reduced 3.23%
90 $0
Q2 2023

Aug 11, 2023

SELL
$9.58 - $13.2 $210 - $290
-22 Reduced 19.13%
93 $0
Q1 2023

May 11, 2023

BUY
$12.12 - $20.8 $12 - $20
1 Added 0.88%
115 $1,000
Q4 2022

Feb 13, 2023

BUY
$9.04 - $16.88 $189 - $354
21 Added 22.58%
114 $1,000
Q3 2022

Nov 10, 2022

SELL
$7.81 - $12.02 $374 - $576
-48 Reduced 34.04%
93 $1,000
Q2 2022

Aug 12, 2022

BUY
$7.14 - $20.36 $214 - $610
30 Added 27.03%
141 $1,000
Q1 2022

May 13, 2022

BUY
$16.3 - $24.65 $1,809 - $2,736
111 New
111 $2,000

Others Institutions Holding GLSI

About Greenwich LifeSciences, Inc.


  • Ticker GLSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,848,200
  • Market Cap $191M
  • Description
  • Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...
More about GLSI
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.